Cosmetic Enhancement Or Care Patents (Class 514/18.8)
-
Patent number: 8288347Abstract: The present specification provides compositions useful as dermal fillers and methods using such compositions to treat a condition of skin.Type: GrantFiled: October 18, 2010Date of Patent: October 16, 2012Assignee: Allergan, Inc.Inventors: Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman
-
Publication number: 20120258059Abstract: It is an object of the present invention to provide a cosmetic or external skin preparation that has an improved feel in use, e.g., excellent stretching on the skin surface, excellent permeation into the skin, and no stickiness, or crinkles. A cosmetic or an external skin preparation, and a medical instrument, comprising at least one lipid peptide-based gelator that contains a low-molecular lipid peptide of Formula (1): (where R1 to R3 are independently an organic group) or a pharmaceutically usable salt thereof.Type: ApplicationFiled: October 26, 2010Publication date: October 11, 2012Applicant: NISSAN CHEMICAL INDUSTRIES, LTD.Inventors: Takehisa Iwama, Keigo Matsumoto, Takayuki Imoto, Nobuhide Miyachi, Masahiro Goto
-
Publication number: 20120245086Abstract: The present invention relates to a WNT10-derived peptide, a composition for improving hair loss and skin conditions using the same, and a composition for treating a WNT10 signal transduction pathway-related disorder and DKK-1 protein-induced disorder using the same. WNT10-derived peptide of the present invention possesses identical or similar activities to natural-occurring WNT10, and has much higher stability and skin penetration potency than natural-occurring WNT10. Therefore, the composition containing the present peptide not only shows excellent effects on improvement in hair loss (for example, promotion of hair growth or production of hair), but also has superior efficacies on treatment of a WNT10 signal transduction pathway-related disorder and a DKK-1 protein-induced disorder. In addition, the outstanding activity and stability of the present peptide described above may be greatly advantageous in application to pharmaceutical compositions, quasi-drugs and cosmetics.Type: ApplicationFiled: November 24, 2009Publication date: September 27, 2012Applicant: CAREGEN CO., LTD.Inventors: Young Ji Chung, Eun Mi Kim, Sang Su Song, Kyoung Mi Cho
-
Publication number: 20120245098Abstract: A topical composition for application to aging skin, comprising an effective amount of S-acyl glutathione derivative of formula (I) wherein R1 consists of an unsaturated or saturated C16 group and R2 is a hydrogen, aliphatic or aromatic acyl group; and a dermatologically acceptable carrier. Preferred compositions comprise about 1.0% to about 3.0% by weight of S-palmitoyl glutathione.Type: ApplicationFiled: March 25, 2011Publication date: September 27, 2012Inventor: NICHOLAS V. PERRICONE
-
Publication number: 20120244208Abstract: This invention relates to a topical cosmetic skin care method and composition. The method and composition is for treating facial skin to cause contraction and tightening of the facial skin, by effecting contraction of the collagen of the skin using an active agent/s that induces fibroblast contraction of the extra cellular matrix of the skin. A preferred active agent is a beta-2-adrenergic receptor (beta2AR) inhibitor.Type: ApplicationFiled: September 6, 2010Publication date: September 27, 2012Inventor: Hugo Barrie Nel
-
Publication number: 20120238506Abstract: The invention relates to a composition containing an extract of seeds of Acacia macrostachya. Advantageously the composition is cosmetic, pharmaceutical, dermatological or nutraceutical. The invention also relates to a method for extracting a Acacia macrostachya seed extract, as well as to the resulting extract. The invention further relates to one such composition or one such extract for use in the prevention or treatment of disorders and diseases affecting the skin, mucosae or appendages, for use in the prevention or treatment of vascular disorders and for use in the prevention or treatment of adipose tissue alterations. Moreover, the invention relates to a method for cosmetic care of the Skin, appendages and mucosae in order to improve the condition or appearance thereof, comprising the administration of one such composition or one such extract.Type: ApplicationFiled: November 30, 2010Publication date: September 20, 2012Inventors: Philippe Msika, Alex Saunois, Sophie Leclere-Bienfait, Caroline Baudoin
-
Publication number: 20120230950Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.Type: ApplicationFiled: May 21, 2012Publication date: September 13, 2012Applicant: Humacyte, Inc.Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler
-
Patent number: 8263046Abstract: Used as cooling agents are the compounds of formula (I), wherein Y is carbonyl (C(?O)) or sulfonyl (SO2—); and X is OCH3, CN, C(?O)NHR, C(?O)OR, or halogen; and R is hydrogen or C1-C4 alkyl.Type: GrantFiled: October 23, 2006Date of Patent: September 11, 2012Assignee: Givaudan S.A.Inventors: Christophe C. Galopin, Lori W. Tigani, Jay Patrick Slack, Pablo Victor Krawec, Lucienne Cole
-
Publication number: 20120225107Abstract: Provided are dermatological compositions for skin and scar treatment, methods of making the compositions and methods of applying the compositions, which result in improved skin and scar whitening performance. In one form, the dermatological composition for skin and scar treatment includes 33 to 60 wt. % of one or more hydrophilic benefiting ingredients, and 40 to 60 wt. % of an anhydrous hydrophilic/amphiphatic base comprising 1 to 35 wt. % of propylene glycol, 1 to 15 wt. % of polyethylene glycol, 1 to 20 wt. % of cetyl alcohol, 1 to 20 wt. % stearyl alcohol, 1 to 10 wt. % of ethoxydiglycol, 0.1 to 2.0 wt. % of dexapanthenol, 0.1 to 1.0 wt. % of phenoxyethanol, and 0.1 to 2.0 wt. % of tocophersolan (TPGS). The one or more hydrophilic benefiting ingredients may include skin whitening agents, antioxidants, extracts, antifungal/antibacterial/anti-acne agents, polypeptides, anti-inflammatory agents, keratolytic agents, amino acids and combinations thereof.Type: ApplicationFiled: March 2, 2012Publication date: September 6, 2012Inventor: Caridad HECHAVARRIA
-
Publication number: 20120213845Abstract: There is disclosed a composition that provides improved anti-aging benefits and creates a healthier skin using the combination of skin exfoliation, brightening, and collagen synthesis. In one embodiment, the composition comprises, a skin exfoliation ingredient such as citric acid and gluconolactone, at least one skin brightening ingredient, such licorice extract, and at least one collagen enhancing ingredient, such as hydroxyproline, bioactive polypeptides or combinations thereof. Depending on the end-use, various optional ingredients, such as moisturizers, anti-inflammatory agents, UVA/UVB protectants, and cleansers, may be added to the composition, which may take various forms, such as a cream, mousse, serum, or gel.Type: ApplicationFiled: October 19, 2011Publication date: August 23, 2012Inventor: Eric F. Bernstein
-
Patent number: 8242076Abstract: A novel laminin polypeptide comprising the amino acid sequence set forth by SEQ ID NO:3 is disclosed. Also disclosed are compositions-of-matter comprising a polysaccharide (e.g., hyaluronic acid) and the novel laminin polypeptide; or hyaluronic acid, a laminin polypeptide and an antioxidant (e.g., superoxide dismutase), as well as matrices and hydrogels comprising same which can be used for ex vivo or in vivo tissue formation and for treatment of pathologies characterized by diseased, damaged or loss of tissue.Type: GrantFiled: August 13, 2008Date of Patent: August 14, 2012Assignees: Ramot at Tel-Aviv University Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Shimon Rochkind, Zvi Nevo
-
Patent number: 8236927Abstract: The invention concerns a method for producing an aqueous albumin solution from a starting albumin solution which contains stabilizer molecules which are capable of occupying binding sites of the albumin, wherein in a method for increasing the albumin binding capacity (ABiC) for other molecules, at least a portion of the stabilizer molecules is removed from the albumin of the starting albumin solution and separated from the starting albumin solution.Type: GrantFiled: May 11, 2006Date of Patent: August 7, 2012Assignee: Albutec GmbHInventor: Katrin Stange
-
Publication number: 20120196790Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.Type: ApplicationFiled: February 14, 2012Publication date: August 2, 2012Applicant: NOVARTIS AGInventors: Philipp KRASTEL, Brigitta-Maria LIECHTY, Josef Gottfried MEINGASSNER, Esther SCHMITT, Erwin Paul SCHREINER
-
Publication number: 20120195979Abstract: The present invention is directed to a treatment composition for recreational water, comprising a high molecular weight water soluble resin composition made from long chain alkoxylated polymers or co-polymers that impart emollient properties to the recreational water, as well as articles of manufacture comprising packaging material and the treatment composition for recreational water contained within the packaging material. The present invention is also directed to methods for treating recreational water, and recreational water treated with the above treatment composition.Type: ApplicationFiled: April 13, 2012Publication date: August 2, 2012Applicant: ARCH CHEMICALS, INC.Inventors: Derek Francis PARISH, Christopher M. ZETENA
-
Patent number: 8231916Abstract: The present invention concerns the use of a rice protein hydrolysate in order to pigment the skin and skin appendages. Thus, it is possible to intensify the normal pigmentation of the skin without sunlight. Preferred areas of applications are repigmentation of white patches of the skin, repigmentation of white patches of the skin as a consequence of pityriasis or due to the use of dermocorticoids; acceleration and intensification of the tanning process, stimulation of the constitutive photoprotection and improvement of the phototype, prevention of skin photocarcinogenesis. Advantageously, the rice protein hydrolysate comprises peptides of which at least 50% have a molecular mass in the range of between 300 and 3,500 Da.Type: GrantFiled: July 18, 2007Date of Patent: July 31, 2012Assignee: Laboratoires ExpanscienceInventors: Philippe Msika, Dalale Naaïmi
-
Publication number: 20120190627Abstract: The present invention is directed to the use, in particular cosmetic use, of an effective amount of at least one lacritin-type polypeptide, of an analogue thereof or of a fragment thereof, of at least one nucleic acid sequence encoding this polypeptide, or of at least one agent that modulates the activity, the stability or the expression of this polypeptide, or its interaction with syndecan-1, as an agent useful for the care of the skin and of appendages thereof.Type: ApplicationFiled: July 16, 2010Publication date: July 26, 2012Applicant: L'OREALInventors: Caroline Delattre, Dominique Bernard, Mark Donovan
-
Publication number: 20120172308Abstract: The present invention relates to the cosmetic use of oligopeptides, cosmetic preparations which comprise such oligopeptides as well as certain oligopeptide derivatives themselves.Type: ApplicationFiled: October 24, 2011Publication date: July 5, 2012Applicant: Cognis France S.A.S.Inventors: Philippe Moussou, Louis Danoux, Gilles Pauly, Jean-Luc Contet-Audonneau
-
Publication number: 20120171144Abstract: Methods of treating, reducing and inhibiting the appearance of ageing in the skin are provided. Also provided are uses and methods of maintaining a youthful appearance, reducing an appearance of ageing, inhibiting an appearance of ageing, reducing a rate of an appearance of ageing, reducing a skin inelasticity, reducing a rate of increasing skin inelasticity, maintaining a skin elasticity, and increasing the density of hair follicles of a skin of a subject comprising applying a granzyme B inhibitor to the skin of the subject. Also provided are methods of identifying a granzyme B inhibitors and agonists.Type: ApplicationFiled: March 9, 2007Publication date: July 5, 2012Inventors: David James Granville, Rani Priya Gomez Cruz
-
Publication number: 20120171265Abstract: The present specification provides for methods for purifying fibroins, purified fibroins, methods of conjugating biological and synthetic molecules to fibroins, fibroins conjugated to such molecules, methods of making fibroin hydrogels, fibroin hydrogels and fibroin hydrogel formulations useful for a variety of medical uses, including, without limitation uses as bulking agents, tissue space fillers, templates for tissue reconstruction or regeneration, cell culture scaffolds for tissue engineering and for disease models, surface coating to improve medical device function, or drug delivery devices.Type: ApplicationFiled: March 14, 2012Publication date: July 5, 2012Applicant: ALLERGAN, INC.Inventors: Gregory H. Altman, Rebecca L. Horan, Adam L. Collette, Jingsong Chen
-
Publication number: 20120172309Abstract: The present invention relates to a peptide of general formula (I): R1-(AA)n-X1-X2-Arg-Arg-Gly-X3-X4-(AA)p-R2. The present invention also relates to a cosmetic or pharmaceutical composition, containing at least one peptide of general formula (I), in a physiologically suitable medium. The present invention also relates to the use of a composition containing the peptide of general formula (I) as an active ingredient which activates human transglutaminase to reinforce the skin barrier function and to stimulate epidermal regeneration and differentiation. The invention also relates to a cosmetic treatment method for preventing and/or for combatting external stresses and signs of skin ageing.Type: ApplicationFiled: August 31, 2010Publication date: July 5, 2012Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20120164182Abstract: The embodiment described herein are related nanoemulsions comprising botulinum toxins. In one embodiment, the nanoemulsions are prepared by high pressure microfluidization and comprise a particle size distribution exclusively between 10 and 300 nm. The nanoemulsions contemplated by the present invention are useful for the cosmetic and medical treatment of muscular contracture states. For example, botulinum toxin may relax facial muscles such that skin wrinkles become smoother and less noticeable. Further, the present invention contemplates a cosmetic formulation that may be self-administered, for example, in the privacy of one's home and without medical supervision.Type: ApplicationFiled: December 1, 2006Publication date: June 28, 2012Inventors: Jonathan Edelson, Robert Nicolosi
-
Publication number: 20120157388Abstract: A moisturizing agent comprising one or more than one compound selected from the group consisting of lysyl-?-alanine represented by the following general formula (1) and a salt thereof:Type: ApplicationFiled: February 23, 2012Publication date: June 21, 2012Inventors: Makoto Tsunenaga, Nobuhiko Ochiai, Mikiko Kaminuma, Masaru Suetsugu
-
Patent number: 8198245Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.Type: GrantFiled: July 24, 2008Date of Patent: June 12, 2012Assignee: Humacyte, Inc.Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler
-
Publication number: 20120135937Abstract: The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.Type: ApplicationFiled: May 28, 2010Publication date: May 31, 2012Applicants: Galderma Research & Development, SymateseInventors: Isabelle Bertholon, Florence Brunel, Benjamin Herbage, Christophe Villard, Sylviane Villard
-
Publication number: 20120134925Abstract: The present invention relates to the uses of the protein PRG4 and therapeutic modulation thereof. In particular, the present invention relates compositions and methods utilizing PRG4 and therapeutic modulation thereof, including, use as a surgical lubricant, use in a treatment for prevention or reduction of post-surgical adhesions, use in a treatment for oral ulcerations, use as an athletic lubricating patch, use as a dermal filler, use in a treatment for dry mouth, use in a drug delivery method or composition, and use in nursing lubrication.Type: ApplicationFiled: May 24, 2010Publication date: May 31, 2012Inventors: Benjamin Sullivan, Tannin Schmidt, Edward R. Truitt, Nicole Barbara Justis Truitt, David Sullivan
-
Publication number: 20120129786Abstract: The present invention relates to compositions comprising a peptide with 2-12 amino acids substituted with a lipophilic moiety and a water soluble salt of an alkali, earth alkaline metal or transition metal. Furthermore, the invention relates to a container comprising such compositions. Additionally, the invention relates to the use of a water soluble salt of an alkali, earth alkaline metal or transition metal for reducing the adhesion of a peptide with 2-12 amino acids substituted with a lipophilic moiety to a surface.Type: ApplicationFiled: April 23, 2010Publication date: May 24, 2012Applicant: DSM IP Assets B.V.Inventors: Marc Heidl, Roman Wille, Hugo Ziegler
-
Publication number: 20120128603Abstract: A cosmetic composition comprises a) an N-acyl amino acid compound selected from the group consisting of N-acyl amino acid, its isomers, its salts, derivatives thereof, and mixtures thereof, and b) hexyldecanol.Type: ApplicationFiled: November 18, 2011Publication date: May 24, 2012Inventor: Shuhei NMN TANAKA
-
Publication number: 20120121725Abstract: The present invention relates to a cosmetic, nutraceutical or dermatological composition for treating or preventing acne, comprising a peptide and oside extract of Schizandra fruit and a suitable excipient. Preferably, the extract is obtained from Schizandra sphenanthera. The composition may also comprise at least one anti-acne agent selected from a sebum-regulating agent, an antibacterial and/or antifungal agent, a keratolytic agent and/or a keratoregulating agent, an astringent, an anti-inflammatory and/or anti-irritant, an antioxidant and/or a free-radical scavenger, a cicatrizing agent, an anti-ageing agent and a moisturizing agent. The invention also relates to a method for cosmetic treatment of acne, characterized in that a cosmetic composition according to the invention is applied to the affected areas of the skin, or in that the affected individual takes a nutraceutical composition according to the invention orally.Type: ApplicationFiled: July 27, 2010Publication date: May 17, 2012Inventors: Sebastien Garnier, Dalale Naaimi, Caroline Baudouin
-
Publication number: 20120114617Abstract: Synthetic peptide including the sequence KKLRIKSKEK (SEQ ID 1) or a sequence of identical size, in which the K residue (in position 1) and the R residue (in position 4) are conserved, the sequence being able to bind to the syndecan-1 receptor.Type: ApplicationFiled: March 15, 2010Publication date: May 10, 2012Applicants: Symatese, Universite Claude Bernard Lyon I, Centre National De La Recherche ScientifiqueInventor: Patricia Rousselle
-
Publication number: 20120114575Abstract: This invention provides a method of preventing or treating in a subject contact dermatitis which comprises administering to the subject an amount of a compound capable of inhibiting the stem cell factor signaling pathway effective to prevent or treating contact dermatitis so as to thereby prevent or treat contact dermatitis in the subject. This invention also provides a method of preventing or treating in a subject hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception.Type: ApplicationFiled: March 15, 2011Publication date: May 10, 2012Inventor: B. Jack Longley
-
Publication number: 20120114577Abstract: The present invention relates to a transforming growth factor-beta (TGF-?)-mimicking peptide containing a particular amino acid sequence and a composition for preventing or treating TGF-?-effective disorders or conditions using the same. The peptide of the present invention may be much higher stability than natural-occurring TGF-? and improve drawbacks caused by high molecular weight of natural-occurring TGF-?. The peptide of this invention can be advantageously applied to treatment or improvement of TGF-?-effective disorders or conditions and have excellent efficacies on skin whitening and wrinkle improvement.Type: ApplicationFiled: April 14, 2009Publication date: May 10, 2012Applicant: CAREGEN CO., LTD.Inventors: Young Ji Chung, Young Deug Kim, Eun Mi Kim, Jeong Jin Choi, Jun Young Choi
-
Publication number: 20120114628Abstract: The present invention relates to the use, especially the cosmetic and/or therapeutic use, of the protein DJ-1, of polypeptides derived from this protein or of analogues thereof, of a nucleic acid sequence coding for such a polypeptide or of a modulator of the activity, stability or expression of such a polypeptide, especially for preventing and/or treating the signs of skin dryness. The invention also relates to the use of the protein DJ-1, of polypeptides derived from this protein or of analogues thereof or of a nucleic acid sequence coding for such a polypeptide, as a marker for evaluating the state of dryness of an epithelium.Type: ApplicationFiled: November 19, 2009Publication date: May 10, 2012Applicant: L'OREALInventors: Dominique Bernard, Lucie Simonetti, Isabelle Castiel
-
Publication number: 20120107410Abstract: The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product.Type: ApplicationFiled: January 28, 2010Publication date: May 3, 2012Applicant: Industrial Farmaceutica Cantabria, S.A.Inventors: Marta Dominguez Valdes-Hevia, Aurora Brieva Delgado, Salvador Gonzalez Rodriguez, Eduardo Reyes Martin, Jose Carballeira Morado, Ernesto Quintana Gonzalez, Juan Pablo Pivel Ranieri, Antonio Guerrero Gomez-Pamo, Angeles Juarranz De La Fuente, Jesus Espada Regalado, Francisco Sanz Rodriguez
-
Publication number: 20120093745Abstract: The present invention concerns a peptidic hydrolyzate enriched in bioactive peptides, said hydrolyzate being a proteasome activator. Further, the present invention concerns a cosmetic or pharmaceutical composition comprising said hydrolyzate in a physiologically acceptable medium and also its use in preventing or treating the signs of aging or photo-aging in skin and protecting the skin against challenges by UV radiation. Finally, the invention concerns a cosmetic treatment method intended to prevent and/or combat the signs of skin aging and photo-aging.Type: ApplicationFiled: April 22, 2010Publication date: April 19, 2012Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20120094921Abstract: The invention concerns a cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, a peptide hydrolyzate which is enriched in soothing bioactive peptide. The invention also concerns the use, in a cosmetic composition, of the active principle in accordance with the invention to activate HMG-CoA reductase in skin cells and to prevent or combat skin irritations.Type: ApplicationFiled: April 15, 2010Publication date: April 19, 2012Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20120094919Abstract: The present invention relates to the use of tripeptide derivatives for tightening, firming and/or moisturizing skin. Furthermore, the invention relates to a method for stimulating the synthesis of glycosaminoglycans containing a D-glucosamine and/or N-acetyl-D-glucosamine residue and/or proteoglycans by fibroblasts and/or keratinocytes such as in particular the synthesis of Hyaluronic acid and/or of the proteoglycans Decorin and/or Lumican.Type: ApplicationFiled: March 16, 2010Publication date: April 19, 2012Inventors: Remo Gräub, Marc Heidl, Dominik Imfeld, Eike Müller, Peter Wikstroem, Hugo Ziegler
-
Publication number: 20120094920Abstract: The invention relates to a peptidic hydrolyzate enriched in bioactive peptide, capable of reinforcing the skin barrier function and stimulating epidermal differentiation. The invention is also relative to a cosmetic and/or pharmaceutical composition comprising, in a physiologically acceptable medium, said hydrolyzate as active principle. The invention further relates to the use, in a cosmetic composition, of the active principle according to the invention to activate the HMG-CoA reductase in the cutaneous cells, and to prevent and combat the cutaneous signs of aging and photo-aging.Type: ApplicationFiled: April 15, 2010Publication date: April 19, 2012Applicant: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20120076842Abstract: The present invention concerns a new cosmetic use of Tyr-Arg dipeptide to stimulate molecules of the extracellular matrix in order to prevent and treat cutaneaous sagging, in particular due to natural gravity. The invention is useful in the preparation of tightening, finning, contouring, and lifting cosmetic products.Type: ApplicationFiled: May 25, 2010Publication date: March 29, 2012Applicant: SEDERMAInventors: Arnaud Fournial, Philippe Mondon
-
Publication number: 20120079614Abstract: The invention concerns compounds, compositions and methods for the treatment of skin cells. Described herein are CD109 polypeptides and uses thereof for the in vivo treatment of various skin disorders, including skin fibrosis, skin scarring, wound healing and psoriasis.Type: ApplicationFiled: February 19, 2010Publication date: March 29, 2012Applicant: The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Anie Philip, Joshua Vorstenbosch, Carter Li, Kenneth Finnson, Hahn Soe-Lin, Xiao-Yong Man, Albane Bizet, Hasan Al-Ajmi
-
Publication number: 20120071414Abstract: The present invention relates to a method for extracting organic molecules and/or organic minerals from a limestone material, including placing said limestone material in contact with a solution including at least one organic solvent, water and at least one acid, as well as to the organic molecules and/or organic minerals produced by the method. The products produced by the method can be used, for example, in therapeutic and non-therapeutic fields, in particular the agri-food, cosmetic and medical fields.Type: ApplicationFiled: April 9, 2010Publication date: March 22, 2012Applicants: Centre National De La Recherche Scientifique-CNRS-, Universite D'Orleans, Museum National D'Histoire NaturelleInventors: Xavier Bourrat, Evelyne Lopez, Marthe Rousseau
-
Patent number: 8138147Abstract: Novel products comprising conditioned cell culture medium compositions and methods of use are described. The conditioned cell medium compositions of the invention may be comprised of any known defined or undefined medium and may be conditioned using any eukaryotic cell type. The medium may be conditioned by stromal cells, parenchymal cells, mesenchymal stem cells, liver reserve cells, neural stem cells, pancreatic stem cells and/or embryonic stem cells. Additionally, the cells may be genetically modified. A three-dimensional tissue construct is preferred. Once the cell medium of the invention is conditioned, it may be used in any state. Physical embodiments of the conditioned medium include, but are not limited to, liquid or solid, frozen, lyophilized or dried into a powder.Type: GrantFiled: January 6, 2009Date of Patent: March 20, 2012Assignee: Skinmedica, Inc.Inventors: Gail K. Naughton, David L. Horwitz, Mark A. Applegate, Joan Zeltinger, Jonathan N. Mansbridge, Andreas Kern, Lee K. Landeen, Anthony Ratcliffe, R. Emmett Pinney
-
Publication number: 20120058952Abstract: The present invention relates to a peptide of general formula (I): R1-(AA)n-X1-Gly-Glu-Leu-Ser-X2-X3-(AA)p-R2, derived from human HMG-CoA reductase. The present invention also relates to a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a physiologically suitable medium. The present invention further relates to the use of this novel peptide as an active principle that activates human HMG-CoA reductase in a cosmetic composition intended to strengthen the barrier function of the skin and to stimulate epidermal differentiation. The invention further applies to a cosmetic treatment method intended to prevent and/or combat the external stresses and signs of cutaneous aging.Type: ApplicationFiled: December 23, 2009Publication date: March 8, 2012Applicant: ISP INVESTMENTS INC.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Patent number: 8124064Abstract: The present invention relates to an in-vitro deposition evaluation method and an system for evaluating deposition of personal care compositions. The method comprises the steps of providing a microplate and at least one body that is capable of movement within the plurality of wells of the microplate. The method comprises the steps of providing a sample that comprises a personal care composition and depositing sufficient volume of sample to submerge a body within the wells of the microplate. The method comprises the steps of providing a skin mimic and contacting the skin mimic and the microplate such that the skin mimic is exposed to the sample and the body. The method comprises the steps of causing at least one body to move wherein a portion of the sample is transferred to the skin mimic and quantifying the amount of the sample that is transferred to the skin mimic.Type: GrantFiled: July 28, 2009Date of Patent: February 28, 2012Assignee: The Procter & Gamble CompanyInventors: Karl Shiqing Wei, Qing Stella
-
Publication number: 20120040912Abstract: The present invention relates to peptidic compounds of general formula (I): R1—X1—X2-Asp-Cys-Arg-X3—X4-(AA)p-R2. In addition, the present invention relates to, on the one hand, a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a cosmetically or pharmaceutically acceptable medium and, on the other hand, its utilization to prevent or treat the cutaneous signs of aging and photo-aging and to protect the skin from aggressions due to UV radiation. Lastly, the invention applies to a cosmetic treatment process intended to prevent and/or combat the cutaneous signs of aging and photo aging.Type: ApplicationFiled: April 1, 2010Publication date: February 16, 2012Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Patent number: 8114439Abstract: The invention relates to peptides of general formula (I): that can reduce or remove bags formed under the eyes, their stereoisomers and racemic or non-racemic mixtures thereof, and the cosmetically or dermopharmaceutically acceptable salts thereof, wherein X is cystenyl, seryl, threonyl or aminobutyryl; R1 is H or alkyl, aryl, aralkyl or acyl group; and R2 is amino, hydroxy or thiol, all of them substituted or non-substituted with aliphatic or cyclic groups. The invention also relates to a method of obtaining, cosmetic or dermopharmaceutical compositions containing them and their use for treating skin, preferably for reducing or removing bags formed under the eyes.Type: GrantFiled: September 22, 2005Date of Patent: February 14, 2012Assignee: Lipotec, S.A.Inventors: Arturo Puig Montiel, Juan Cebrían Puche, Elena Passerini
-
Publication number: 20120027878Abstract: Natural lycopene concentrate obtained from a plant structure after alkalinization, solid-liquid separation, acidification and a second solid-liquid separation. The concentrate obtained is highly bioavailable and water-soluble at room temperature.Type: ApplicationFiled: October 4, 2011Publication date: February 2, 2012Applicant: NESTEC S.A.Inventors: Karlheinz Bortlik, Eliane Duruz, Eric Kolodziejczyk, Marie-Rose Fernandez-Graf
-
Publication number: 20120027699Abstract: Skin care compositions comprising certain substituted monoamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.Type: ApplicationFiled: July 29, 2010Publication date: February 2, 2012Applicant: CONOPCO, INC., D/B/A UNILEVERInventors: Jose Guillermo ROSA, Bijan HARICHIAN, Diana Jean DRENNAN, John Steven BAJOR, Carol Annette BOSKO
-
Publication number: 20120027705Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.Type: ApplicationFiled: October 6, 2011Publication date: February 2, 2012Applicant: REGENICS ASInventors: Runhild Gammelsaeter, Jan Remmereit
-
Publication number: 20120027703Abstract: The present invention relates to peptidic compounds of general formula (I): R1-X1-Arg-Lys-Gly-X2-R2. In addition, the present invention relates to, on the one hand, a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a cosmetically or pharmaceutically acceptable medium and, on the other hand, its utilization to prevent or treat the cutaneous signs of aging and photo-aging and to protect the skin from aggressions due to UV radiation. Lastly, the invention applies to a cosmetic treatment process intended to prevent and/or combat the cutaneous signs of aging and photo aging.Type: ApplicationFiled: April 1, 2010Publication date: February 2, 2012Applicant: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20120027700Abstract: Skin care compositions comprising certain substituted diamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.Type: ApplicationFiled: July 29, 2010Publication date: February 2, 2012Applicant: Conopco, Inc., d/b/a UNILEVERInventors: Jose Guillermo Rosa, Bijan Harichian, Diana Jean Drennan, John Steven Bajor, Carol Annette Bosko